IWP Capital urges FedEx shareholders to back abortion-drug shipping risk report at Sept. 28 meeting - FDX News | RalliesIWP Capital urges FedEx shareholders to back abortion-drug shipping risk report at Sept. 28 meeting
F
FDX• Risk concerns cited by co-filers
- Co-filers cite uncertainty over potential Comstock Act enforcement as a material risk factor for the company’s distribution practices.
Shareholder proposal at Sept. 28 meeting
- IWP Capital plans to vote for Proposal 6 at FedEx’s Sept. 28 annual meeting.
- Proposal seeks a board report within one year on legal, regulatory, reputational risks tied to shipping abortion drugs such as mifepristone.
